Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTOK0LR)

DTT Name	Toll-like receptor (TLR) DTT Info
Gene Name	TLR

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Discontinued Drug(s)

Clinical Trial Drug(s)

Patented Agent(s)

Download the Complete Related Drug List

4 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
BDB001	DMKFJXP	Solid tumour/cancer	2A00-2F9Z	Phase 2	[1]
DPV-001	DMMC3XR	Non-small-cell lung cancer	2C25.Y	Phase 2	[2]
IMO-8400	DMDPNCJ	Rheumatoid arthritis	FA20	Phase 2	[3]
IMO-9200	DMEHWPC	Autoimmune disease	4A40-4A45	Phase 1	[4]
------------------------------------------------------------------------------------

12 Patented Agent(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
PMID30280939-Compound-US20170128558	DMM83WL	Malaria	1F40-1F45	Patented	[5]
PMID30280939-Compound-US20179642901	DMPVW2Q	Malaria	1F40-1F45	Patented	[5]
PMID30280939-Compound-WO2005070959	DM6VP5K	N. A.	N. A.	Patented	[5]
PMID30280939-Compound-WO200606195	DMLVSEK	N. A.	N. A.	Patented	[5]
PMID30280939-Compound-WO2008009652	DM7DG0M	Malaria	1F40-1F45	Patented	[5]
PMID30280939-Compound-WO2009082440	DMXRHCJ	N. A.	N. A.	Patented	[5]
PMID30280939-Compound-WO2013119856	DMRB7LI	N. A.	N. A.	Patented	[5]
PMID30280939-Compound-WO2013148426	DMUKIEJ	Malaria	1F40-1F45	Patented	[5]
PMID30280939-Compound-WO2013148427	DM4Z2KY	N. A.	N. A.	Patented	[5]
PMID30280939-Compound-WO2015035128	DM4ILAK	N. A.	N. A.	Patented	[5]
PMID30280939-Compound-WO2015091734	DM5K3DF	Malaria	1F40-1F45	Patented	[5]
PMID30280939-Compound-WO2015150568	DMGCE3Z	N. A.	N. A.	Patented	[5]
------------------------------------------------------------------------------------


⏷ Show the Full List of 12 Patented Agent(s)

1 Discontinued Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ONO-4007	DMIZXFJ	Immune System disease	4A01-4B41	Discontinued in Phase 2	[6]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	UbiVac's DRibble, autophagosome-enriched vaccines: Applications for cancer and infectious disease. UbiVac. 2013.
3	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
5	Synthetic Toll-like receptor agonists for the development of powerful malaria vaccines: a patent review.Expert Opin Ther Pat. 2018 Nov;28(11):837-847.
6	Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products. Clin Exp Immunol. 2006 August; 145(2): 346-356.